Chen et al. verified that YBX1 can bind the m5C methylation site in the HDGF 3’ untranslated region catalyzed by NSUN2 and stabilize HDGF mRNA to drive bladder cancer progression [21]. Here, YBX1 is linked to urinary bladder carcinoma.